These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6572436)

  • 1. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 4. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacterial microflora in acute suppurative odontogenic diseases of the maxillofacial area].
    Bazhanov NN; Pashkov EP; Kultaev MS; Chikorin AK; Nabokov IuS
    Stomatologiia (Mosk); 1985; 64(1):31-2. PubMed ID: 3857733
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of alginic acid-based preparations for treating suppurative wounds of the maxillofacial area and neck].
    Ushakov RV; Dugarov BD; Iakubovich VS; Komissarova AL; Shargorodskiĭ VM
    Stomatologiia (Mosk); 1991; (5):46-7. PubMed ID: 1724711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of quercetin granules for treating suppurative soft-tissue wounds of the maxillofacial area and neck].
    Timofeev AA; Maksiutina NP; Voĭtenko GN; Dobrovol'skiĭ IuN
    Stomatologiia (Mosk); 1989; 68(6):11-3. PubMed ID: 2623676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
    Chernoglazova EM
    Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of proteolyic enzymes and nucleases in the complex treatment of acute and chronic odontogenic inflammatory processes of the maxillofacial region].
    Korchak LF
    Zh Ushn Nos Gorl Bolezn; 1972; (3):75-80. PubMed ID: 4680880
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 13. [The intestinal microflora of patients with inflammatory diseases of the maxillofacial area].
    Bevz NI; Budanova EV; Pashkov EP; Ter-Asaturov GP; Goncharova GI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):22-4. PubMed ID: 7992527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].
    Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI
    Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of using baliz-2 for treating suppurative wounds of the soft tissues].
    Timofeev AA
    Sov Med; 1988; (12):116. PubMed ID: 3242110
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of chlorhexidine bigluconate in the combined treatment of inflammatory periodontal diseases].
    Chuchmaĭ GS; Kordis MS; Akimova AIa
    Stomatologiia (Mosk); 1985; 64(3):27-9. PubMed ID: 3863273
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.